Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-050766
Filing Date
2009-03-11
Accepted
2009-03-11 15:31:06
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1016954
2 COLLABORATION AGREEMENT BETWEEN NAPO PHARMACEUTICALS AND SALIX dex1064.htm EX-10.64 758858
3 MANUFACTURING AND SUPPLY AGREEMENT BETWEEN SALIX AND GLENMARK dex1065.htm EX-10.65 274284
4 SALIX PHARMACEUTICALS, LTD. SUBSIDIARIES dex211.htm EX-21.1 3159
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1563
6 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 3686
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 10027
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10077
9 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3144
10 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3407
11 GRAPHIC g52794g52j14.jpg GRAPHIC 42174
  Complete submission text file 0001193125-09-050766.txt   2144884
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 09672410
SIC: 2834 Pharmaceutical Preparations